Company Filing History:
2 out of 57 
1 out of 21 
1 out of 10 Years Active: 2006-2020
Title: The Innovator Cristina Esteve Trias: Pioneering JAK Inhibitors
Introduction
Cristina Esteve Trias, an accomplished inventor based in Barcelona, Spain, has made significant contributions to the field of pharmaceutical innovations, particularly in the development of targeted therapies. With a remarkable portfolio of four patents, she is at the forefront of research aimed at combating various health conditions through innovative drug compounds.
Latest Patents
Among her noteworthy inventions are two latest patents that demonstrate her expertise in medicinal chemistry. The first patent focuses on 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as Janus Kinase (JAK) inhibitors. This patent discloses new derivatives alongside processes for their preparation, pharmaceutical compositions comprising them, and their therapeutic applications as powerful inhibitors of JAK. The second patent presents 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives, which are described as new inhibitors of the p38 mitogen-activated protein kinase. This innovation includes details on their preparation processes, compositions, and therapeutic utility.
Career Highlights
Cristina has built a notable career, collaborating with leading pharmaceutical companies. She has worked at Almirall, S.A., and Almirall Prodesfarma S.A., where she contributed her expertise to various research projects aimed at developing effective therapeutic solutions. Her role in these organizations has highlighted her commitment to progressing innovative healthcare.
Collaborations
Within her professional journey, Cristina has had the opportunity to collaborate with distinguished colleagues, including Bernat Vidal Juan and Jacob Gonzalez Rodriguez. These collaborations have enhanced her research efforts and fostered a shared vision for developing groundbreaking pharmaceutical innovations.
Conclusion
Cristina Esteve Trias stands out as a transformative figure in the realm of pharmaceuticals. Her dedication to research and development, combined with her innovative patent contributions, places her at the cutting edge of invention in the healthcare sector. Through her work, she continues to inspire future generations of inventors and contribute to advancements in medical science.